BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 16822461)

  • 21. Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia.
    Carlsson G; Melin M; Dahl N; Ramme KG; Nordenskjöld M; Palmblad J; Henter JI; Fadeel B
    Acta Paediatr; 2007 Jun; 96(6):813-9. PubMed ID: 17537008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-myeloablative transplantation for severe congenital neutropenia.
    Thachil J; Caswell M; Bolton-Maggs PH; Pizer B; Keenan R
    Pediatr Blood Cancer; 2008 Apr; 50(4):920-1. PubMed ID: 17635003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
    Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
    Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Severe congenital neutropenia: analysis of clinical features, diagnostic methods, treatment and long-term outcome].
    Milá M; Rufach A; Dapena JL; Arostegui JI; Elorza I; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2011 Dec; 75(6):396-400. PubMed ID: 21757412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic growth factors for the treatment of inherited cytopenias.
    Zeidler C; Welte K
    Semin Hematol; 2007 Jul; 44(3):133-7. PubMed ID: 17631177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular screening of the neutrophil elastase gene in congenital neutropenia.
    Thomas M; Jayandharan G; Chandy M
    Indian Pediatr; 2006 Dec; 43(12):1081-4. PubMed ID: 17202606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe chronic neutropenia: pathophysiology and therapy.
    Welte K; Boxer LA
    Semin Hematol; 1997 Oct; 34(4):267-78. PubMed ID: 9347577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia.
    Sera Y; Kawaguchi H; Nakamura K; Sato T; Habara M; Okada S; Ishikawa N; Kojima S; Katoh O; Kobayashi M
    Haematologica; 2005 Aug; 90(8):1032-41. PubMed ID: 16079102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe congenital neutropenia: inheritance and pathophysiology.
    Skokowa J; Germeshausen M; Zeidler C; Welte K
    Curr Opin Hematol; 2007 Jan; 14(1):22-8. PubMed ID: 17133096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and control of infections in patients with severe congenital neutropenia; a follow up study.
    Salehi T; Fazlollahi MR; Maddah M; Nayebpour M; Tabatabaei Yazdi M; Alizadeh Z; Eshghi P; Chavoshzadeh Z; Movahedi M; Hamidieh AA; Cheraghi T; Pourpak Z; Moin M
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):51-6. PubMed ID: 22427476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic neutropenia].
    Palmblad J; Elinder G
    Nord Med; 1996 Nov; 111(9):304-7. PubMed ID: 8966113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe congenital neutropenias.
    Skokowa J; Dale DC; Touw IP; Zeidler C; Welte K
    Nat Rev Dis Primers; 2017 Jun; 3():17032. PubMed ID: 28593997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
    Nasri M; Ritter MU; Mir P; Dannenmann B; Kaufmann MM; Arreba-Tutusaus P; Xu Y; Borbaran-Bravo N; Klimiankou M; Lengerke C; Zeidler C; Cathomen T; Welte K; Skokowa J
    Mol Ther; 2024 Jun; 32(6):1628-1642. PubMed ID: 38556793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
    Freedman MH; Alter BP
    Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe congenital neutropenia and the unfolded protein response.
    Xia J; Link DC
    Curr Opin Hematol; 2008 Jan; 15(1):1-7. PubMed ID: 18043239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic and chronic neutropenia.
    Dale DC; Welte K
    Cancer Treat Res; 2011; 157():97-108. PubMed ID: 21052952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Granulopoeisis and leukemogenesis: lessons from congenital neutropenia].
    Donadieu J; Beaupain B; Bellanné-Chantelot C
    Med Sci (Paris); 2008 Mar; 24(3):284-9. PubMed ID: 18334177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital neutropenia: From lab bench to clinic bedside and back.
    Dobrewa W; Bielska M; Bąbol-Pokora K; Janczar S; Młynarski W
    Mutat Res Rev Mutat Res; 2024; 793():108476. PubMed ID: 37989463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia.
    Germeshausen M; Schulze H; Kratz C; Wilkens L; Repp R; Shannon K; Welte K; Ballmaier M
    Leukemia; 2005 Apr; 19(4):611-7. PubMed ID: 15729385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.